Real-world Evidence from a Retrospective Multicentre Analysis on First-line Therapy for Metastatic Papillary Renal Cell Carcinoma. A GUARDIANS Project

Background and objective: Papillary renal cell carcinoma (pRCC) is a rare disease. The optimal treatment of metastatic pRCC is still unclear. We evaluated real-world treatment outcomes of first-line treatment in this cohort in Germany. Methods: Patients with advanced or metastatic pRCC were eligible...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Thomas Hilser, Jozefina Casuscelli, Can Aydogdu, Stefanie Zschäbitz, Marco Julius Schnabel, Emily Rinderknecht, Angelika Mattigk, Martin Schostak, Anna-Lisa Volk, Philipp Ivanyi, Jonas Wiegmann, Christopher Darr, Luka Flegar, Subhajit Mandal, Katrin Schlack, Daniel Seidl, Analena Handke, Melanie Klee, Tim Nestler, Marc Rehlinghaus, Sameh Hijazi, Axel Heidenreich, Viktor Grünwald, Pia Paffenholz
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Elsevier 2025-08-01
Цуврал:	European Urology Open Science
Нөхцлүүд:	Papillary renal cell cancer Immune checkpoint inhibitor Tyrosine kinase inhibitor First-line treatment
Онлайн хандалт:	http://www.sciencedirect.com/science/article/pii/S2666168325002447
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!